Serum concentrations of valproic acid in people with epilepsy: Clinical implication

Serum concentrations of valproic acid in people with epilepsy: Clinical implication

Context: Therapeutic drug monitoring (TDM) allows personalizing the dose of valproic acid in patients with epilepsy to optimize drug therapy, minimize adverse effects and detect interactions. Aims: To determine valproic acid concentrations in serum samples from people with epilepsy and to analyze...

Full description

Bibliographic Details
Main Authors:	Angel T. Alvarado, Juan Cotuá, Maryori Delgado, Alexis Morales, Ana María Muñoz, César Li Amenero, María R. Bendezú, Jorge A. García, Doris Laos-Anchante, Felipe Surco-Laos, Berta Loja, Mario Bolarte-Arteaga, Mario Pineda-Pérez
Format:	Article
Language:	English
Published:	GarVal Editorial Ltda. 2022-11-01
Series:	Journal of Pharmacy & Pharmacognosy Research
Subjects:	dose-dose relationship epilepsy serum concentration therapeutic monitoring valproic acid
Online Access:	https://jppres.com/jppres/pdf/vol10/jppres22.1500_10.6.1117.pdf

Similar Items

Cost analysis of epilepsy pharmacotherapy by valproic acid and carbamazepine
by: Ia. O. Grynkiv, et al.
Published: (2018-08-01)

Meta-analysis of plasma homocysteine levels in valproic acid treated patients with epilepsy
by: Guan-zhong NI, et al.
Published: (2014-12-01)

Evaluation of Cardiac Repolarization Indices in Epilepsy Patients Treated with Carbamazepine and Valproic Acid
by: Ramazan Asoğlu, et al.
Published: (2020-01-01)

A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center
by: Marco Carli, et al.
Published: (2022-01-01)

Valproic acid-associated pancytopenia: A dose-dependent adverse effect
by: Jamir Pitton Rissardo, et al.
Published: (2019-09-01)

Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy
by: Tiantian Liang, et al.
Published: (2024-04-01)

Process of Personalized Prescription of Valproic Acid as the Main Element of the Management of Epilepsy
by: Elena N. Bochanova, et al.
Published: (2018-03-01)

Determination of elemental impurities in valproic acid an epilepsy drug by using ICP-MS
by: Satish Ganta, et al.
Published: (2022-12-01)

Frequency of Subclinic Hypothyroidism at the Patients That Are Using Valproic Acid
by: Mehmet Ibrahim Turan, et al.
Published: (2014-06-01)

All guns blazing: management and survival of massive valproic acid overdose – case report and literature review
by: Al Jawder S, et al.
Published: (2018-01-01)

Determination of the factors that cause valproic acid resistance in the pediatric juvenile myoclonic epilepsy cohort
Published: (2022-03-01)

USE OF VALPROIC ACID IN WOMEN WITH EPILEPSY DURING PREGNANCY
by: A. V. Yakunina, et al.
Published: (2017-11-01)

Effect of valproic acid on metabolic status and endocrine system in pediatric patients with epilepsy: systematic literature review
by: Sona Sepahi, et al.
Published: (2017-01-01)

Pentylenetetrazole-induced seizures in developing rats prenatally exposed to valproic acid
by: Angel A. Puig-Lagunes, et al.
Published: (2016-11-01)

Phenytoin concentration in people with epilepsy: a comparative study in serum and saliva
by: Angel Alvarado, et al.
Published: (2022-08-01)

Effects of Valproic acid drug on Hepatic tissues in female mice
by: El-nagi O. M. El-nagaz, Tarek A. Guseibat, Omelaz A. M. Elturshani, Khalida R. Al-Sarraj, Amal El-Tarhouni
Published: (2020-10-01)

Association of ABCB1 Polymorphisms with Efficacy and Adverse Drug Reactions of Valproic Acid in Children with Epilepsy
by: Jiahao Zhu, et al.
Published: (2023-10-01)

Therapeutic monitoring of valproic acid - benefits and problems
by: Agnieszka Małgorzata Cios, et al.
Published: (2021-05-01)

Serum Leptin Levels in Epileptic Patients Treated with Topiramate and Valproic Acid
by: İrem Fatma Uludağ, et al.
Published: (2011-03-01)

Serum Leptin Levels in Epileptic Patients Treated with Topiramate and Valproic Acid
by: İrem Fatma Uludağ, et al.
Published: (2011-03-01)

The potential antiepileptic activity of astaxanthin in epileptic rats treated with valproic acid
by: Yussra Ata Yaseen Abdulqader, et al.
Published: (2021-05-01)

Diacylglycerol kinase (DGKA) regulates the effect of the epilepsy and bipolar disorder treatment valproic acid in Dictyostelium discoideum
by: Elizabeth Kelly, et al.
Published: (2018-09-01)

Comparison of effects and electrophysiological mechanisms of action of valproic acid and levetyracetam in an experimental model of focal epilepsy
by: Svetlana A. Litvinova, et al.
Published: (2018-10-01)

Chronic valproic acid intoxication in epileptology: diagnosis and treatment
by: N. A. Shnaider, et al.
Published: (2016-07-01)

EXPERIENCE REPLACEMENT DRUGS OF VALPROIC ACID IN CHILDREN OUTPATIENT CLINIC
by: I. O. Schederkina, et al.
Published: (2016-05-01)

Comparative analysis of valproic acid concentrations in terms of dosing and clinical effect monitoring in different age patients with diagnosed epilepsy
by: Agnieszka Cios, et al.
Published: (2022-05-01)

Shifting Valproic Acid to Levetiracetam in Women of Childbearing Age With Epilepsy: A Retrospective Investigation and Review of the Literature
by: Cheng-Yen Kuo, et al.
Published: (2020-04-01)

Large subgaleal hematoma caused by valproic acid: a case report
by: Aldo José F da Silva, et al.
Published: (2020-12-01)

Characterization of polyunsaturated fatty acids and antioxidant activity of Vitis vinifera L. (grape) seeds from the Ica Valley, Peru
by: Felipe Surco-Laos, et al.
Published: (2023-03-01)

Valproic-induced Fanconi syndrome: Clinical features, risk factors, diagnosis and management
by: Chunjiang Wang, et al.
Published: (2022-09-01)

Effects of valproic acid on skeletal metabolism in children with epilepsy: a systematic evaluation and meta-analysis based on 14 studies
by: Li Min, et al.
Published: (2020-03-01)

Direct Determination of a Small-Molecule Drug, Valproic Acid, by an Electrically-Detected Microcantilever Biosensor for Personalized Diagnostics
by: Long-Sun Huang, et al.
Published: (2015-01-01)

Abamectin and emamectin in grapes of Vitis vinifera L. from a district of the Valley of Ica-Peru
by: Angel T. Alvarado, et al.
Published: (2023-09-01)

Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients
by: Paulo Teixeira-da-Silva, et al.
Published: (2022-04-01)

Valproic Acid and Thrombocytopenia
by: J Gordon Millichap
Published: (1996-08-01)

Possible pathogenetic mechanisms of failure epilepsy treatment with carbamazepine
by: K. V. Krikova, et al.
Published: (2016-08-01)

Neurocognitive Evaluation in Epilepsy Patients Treated with Monotheraphy: A Preliminary Report
by: Ahmet EVLİCE, et al.
Published: (2016-08-01)

PHARMACO-ECONOMIC EVALUATION OF THE USE OF VALPROATES IN TABLET FORMS IN EPILEPSY THERAPY
by: P. A. Balunov
Published: (2017-05-01)

Genetic Variations of Gene Associated with Adverse Drug Reactions to Valproic Acid in Korean Epileptic Patients
by: Ji Hyun Yi, et al.
Published: (2013-12-01)

Genetic and Non-genetic Factors Contributing to the Significant Variation in the Plasma Trough Concentration-to-Dose Ratio of Valproic Acid in Children With Epilepsy
by: Ze-Yue Xu, et al.
Published: (2021-01-01)